{"transactions":[{"id":4028295,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-03-01T00:19:50.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018."}],"balance_after":200000,"derivative":{"exercise_price":0.78,"expiration_date":"2023-02-26","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-014705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118014705/doc4.xml","form_type":"4"}},{"id":4201133,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Warrant","published_at":"2017-09-27T22:17:27.000Z","date":"2017-09-25","kind":"exercise","acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the terms of the Issuer's tender offer, the Reporting Person exercised his 2014 Warrant in full and in cash on September 25, 2017."}],"balance_after":0,"derivative":{"exercise_price":0.6,"exercise_date":"2014-07-02","expiration_date":"2017-09-25","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-17-054171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117054171/doc4.xml","form_type":"4"}},{"id":4201132,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Warrant","published_at":"2017-09-27T22:17:27.000Z","date":"2017-09-25","kind":"grant","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the \"2014 Warrants\"), on November 23, 2015 (the \"2015 Warrants\") and on January 23, 2017 (the \"2017 Warrants\").  As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017.  The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer.  As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the \"2014 Warrants\"), on November 23, 2015 (the \"2015 Warrants\") and on January 23, 2017 (the \"2017 Warrants\").  As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017.  The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer.  As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended."}],"balance_after":16000,"derivative":{"exercise_price":0.6,"exercise_date":"2014-07-02","expiration_date":"2017-09-25","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-17-054171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117054171/doc4.xml","form_type":"4"}},{"id":4201131,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Warrant","published_at":"2017-09-27T22:17:27.000Z","date":"2017-09-25","kind":"disposition_to_issuer","acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the \"2014 Warrants\"), on November 23, 2015 (the \"2015 Warrants\") and on January 23, 2017 (the \"2017 Warrants\").  As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017.  The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer.  As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 25, 2017, the Issuer completed the initial closing of a tender offer in which the Issuer offered to amend the terms of the outstanding warrants the Issuer issued to investors participating in private placement financings the Issuer completed on August 29, 2014 (the \"2014 Warrants\"), on November 23, 2015 (the \"2015 Warrants\") and on January 23, 2017 (the \"2017 Warrants\").  As part of the tender offer and in order to raise funds to support its continued operations, the Issuer offered to reduce the respective exercise prices of the 2014, 2015 and 2017 Warrants if the holders agreed to exercise their Warrants in cash by September 25, 2017.  The Reporting Person holds a 2014 Warrant and elected to participate in the Issuer's tender offer.  As a result, the exercise price and the expiration date, among other terms, of the 2014 Warrant held by the Reporting Person were amended."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2014-07-02","expiration_date":"2019-07-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-17-054171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117054171/doc4.xml","form_type":"4"}},{"id":4201130,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2017-09-27T22:17:27.000Z","date":"2017-09-25","kind":"exercise","acquired":true,"shares":16000,"price":0.6,"value":9600.0,"ownership":{"direct":true},"balance_after":556000,"source":{"system":"sec-edgar","filing":"0001209191-17-054171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117054171/doc4.xml","form_type":"4"}},{"id":4272840,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-06-26T20:59:53.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option shares shall vest and become exercisable on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter."}],"balance_after":1000000,"derivative":{"exercise_price":1.19,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-17-041856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117041856/doc4.xml","form_type":"4"}},{"id":4272839,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2017-06-26T20:59:53.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (the \"RSUs\"). 25% of the RSUs vest on December 31, 2018 with the remaining shares vesting in 3 equal annual installments thereafter.  Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the Grant Date; (ii) sixty days after the date the Grantee's Service ceases for any reason and such cessation constitutes a \"separation from service\" within the meaning of Section 409A of the Code; (iii) the date of Grantee's death or (iv) the date of a Change in Control that constitutes a \"change in control event\" within the meaning of Section 409A of the Code."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the cancellation of 2,800,000 Restricted Stock Units pursuant to an RSU Cancellation Agreement, dated December 13, 2016."}],"balance_after":540000,"source":{"system":"sec-edgar","filing":"0001209191-17-041856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117041856/doc4.xml","form_type":"4"}},{"id":4405896,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":168913,"kind":"person","name":"Pfanzelter David J","position":1,"cik":"0001569467","reported_name":"Pfanzelter David J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-03T23:28:25.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on April 30, 2017, July 31, 2017, October 31, 2017 and January 31, 2018."}],"balance_after":200000,"derivative":{"exercise_price":0.88,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-17-017991","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117017991/doc4.xml","form_type":"4"}}]}